Oxford Instruments/£OXIG

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Oxford Instruments

Oxford Instruments plc, trading under the ticker OXIG, is a provider of high technology products and services, primarily targeted at the industry and scientific research communities. The company operates within the technology sector, specializing in tools and systems used across various industries for research and development. Founded in 1959, Oxford Instruments has grown to establish a global presence, supporting customers in their quest for scientific excellence and innovation.

Ticker

£OXIG

Sector

Digital Hardware

Primary listing

LSE

Employees

2,169

OXIG Metrics

BasicAdvanced
£1B
41.35
£0.44
0.95
£0.22
1.21%

What the Analysts think about OXIG

Analyst ratings (Buy, Hold, Sell) for Oxford Instruments stock.

Bulls say / Bears say

Oxford Instruments has agreed to sell its NanoScience quantum division for £60 million and announced a £50 million share buyback, intensifying its focus on higher-margin businesses and returning capital to shareholders (Oxford Instruments)
Full-year revenue topped £500 million for the first time, growing 6.5% on a constant currency basis, thanks to strong demand in semiconductors and materials analysis (Oxford Instruments)
Adjusted operating profit margin rose 70 basis points year-over-year on a constant currency basis to 17.8%, supported by operational efficiencies and a streamlined two-division model, with Imaging & Analysis margin up 60 basis points to 24.7% (Oxford Instruments)
Overall book-to-bill ratio dropped to 0.93x in FY25 (Advanced Technologies at 0.85x), down from 1.03x the previous year, pointing to slower order momentum and reduced revenue visibility for FY26 (Investing.com)
Ongoing weakness in the healthcare & life science division offset gains in the semiconductor and materials analysis units, capping total revenue growth and reflecting softer OEM and microscope demand (Oxford Instruments)
Jefferies analysts caution that U.S. clients may postpone deliveries until tariff conditions are clear, creating a risk of order deferrals and near-term revenue delays in H1 FY26 (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.

OXIG Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OXIG Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £OXIG

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs